English Français

Strategy is in our DNA.

Every day, our consultants help leaders across the life sciences ecosystem make better strategic, financial and operational decisions.

Learn more
WHO WE SERVE

We support the companies that move healthcare forward

Pharma
Pharma
Build winning portfolios, accelerate innovation and drive sustainable growth
chevron-red Learn more
Biotech
Biotech
Translate breakthrough science into commercial success
chevron-red Learn more
Medtech
Medtech
Bring impactful technologies to market and lead in fast-moving healthcare markets
chevron-red Learn more
Private Equity
Private Equity
Make better deals, grow stronger companies, and deliver higher returns
chevron-red Learn more
Contract Service Providers
Contract Service Providers
Stand out, win clients, operate smarter and stay ahead of customer expectations
chevron-red Learn more
Product Suppliers
Product Suppliers
Unlock the full potential of your organization and secure market leadership
chevron-red Learn more
TRACK RECORD

Unmatched industry expertise

500+
Larka consultants and external experts
30+
Years of hands-on experience in the biopharma industry
400+
Clients served globally since 1993
700Mn
Industry data collected each year via our BI platform
OUR CLIENTS

Trusted by leading life science organizations and investors worldwide.

Albumedix
Idorsia
Pfizer
Warburg Pincus
GE HealthCare
Eurazeo
Sartorius
GHO Capital
Recipharm
GSK
Cytiva
Sanofi
Siemens Healthineers
Danaher
Albumedix
Idorsia
Pfizer
Warburg Pincus
GE HealthCare
Eurazeo
Sartorius
GHO Capital
Recipharm
GSK
Cytiva
Sanofi
Siemens Healthineers
Danaher
Abbott
Catalent
Advent International
Merck
Johnson & Johnson
TA Associates
Thermo Fisher Scientific
Novartis
Keensight Capital
Adocia
Gedeon Richter
MC2 Therapeutics
Piramal Pharma Solutions
CordenPharma
Abbott
Catalent
Advent International
Merck
Johnson & Johnson
TA Associates
Thermo Fisher Scientific
Novartis
Keensight Capital
Adocia
Gedeon Richter
MC2 Therapeutics
Piramal Pharma Solutions
CordenPharma
RESOURCES

Featured resources

  • CASE STUDY

    Strategic review of early-stage oncology assets

    Read more
  • NEWS

    Larka Advises Afinum on Its Acquisition of ProJect Pharmaceutics

    Read more
  • REPORT

    Biotech Venture Capital Report 2024

    Read more
  • REPORT

    Biotech Funding: Why ADCs Became VC Magnets in 2024

    Read more
  • CASE STUDY

    Build vs. buy decision-making

    Read more
  • CASE STUDY

    Targeted reassessment of returned oncology assets

    Read more

Ready to talk?

Get in touch with our industry experts.

Contact us